Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.05 is 48% below its 5-year average of 5.86, near the low end of its 5-year range (0.00–31.48).
As of the fiscal period ended Tuesday, June 30, 2026. 30.13% below its 12-month average of 4.37.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.05.
QUICK RATIO (ACID-TEST)
3.05
QUICK RATIO (ACID-TEST) AVG TTM
4.37
QUICK RATIO (ACID-TEST) AVG 3Y
5.44
QUICK RATIO (ACID-TEST) AVG 5Y
5.86
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-30.13%
CURRENT VS 3Y AVG
-43.82%
CURRENT VS 5Y AVG
-47.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-8.96%
vs the sector median at left
Prime Medicine, Inc.
Market Cap
$632.16M
Quick Ratio (Acid-Test)
3.05
TTM Avg
4.37
3Y Avg
5.44
5Y Avg
5.86
Market Cap
$634.30M
Quick Ratio (Acid-Test)
5.12
TTM Avg
4.05
3Y Avg
4.17
5Y Avg
7.50
Market Cap
$638.20M
Quick Ratio (Acid-Test)
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$619.15M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.67
3Y Avg
4.11
5Y Avg
5.17
Market Cap
$611.57M
Quick Ratio (Acid-Test)
31.45
TTM Avg
23.29
3Y Avg
26.88
5Y Avg
23.21
Market Cap
$656.59M
Quick Ratio (Acid-Test)
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$657.89M
Quick Ratio (Acid-Test)
1.15
TTM Avg
1.35
3Y Avg
1.35
5Y Avg
1.35
Market Cap
$660.29M
Quick Ratio (Acid-Test)
5.53
TTM Avg
8.02
3Y Avg
10.47
5Y Avg
14.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prime Medicine, Inc. (PRME) | $632.16M | 3.05 | 4.37 | 5.44 | 5.86 |
| OmniAb, Inc. (OABI)vs › | $630.63M | 4.80 | 4.27 | 4.36 | 3.29 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 5.12 | 4.05 | 4.17 | 7.50 |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | 16.82 | 9.46 | 14.12 | 14.05 |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | 2.55 | 2.67 | 4.11 | 5.17 |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | 31.45 | 23.29 | 26.88 | 23.21 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | 8.03 | 12.16 | 13.50 | 14.42 |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | 1.15 | 1.35 | 1.35 | 1.35 |
| Annexon, Inc. (ANNX)vs › | $660.29M | 5.53 | 8.02 | 10.47 | 14.43 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 6.06 | 2.91 | 9.30 | 9.54 |
Quick Ratio
3.05
Excludes inventory
Current Ratio
3.05
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.05 |
| 2026-03-31 | 3.80 |
| 2025-12-31 | 4.84 |
| 2025-09-30 | 6.61 |
| 2025-06-30 | 3.56 |
| 2025-03-31 | 4.78 |
| 2024-12-31 | 5.58 |
| 2024-09-30 | 6.50 |
| 2024-06-30 | 8.23 |
| 2024-03-31 | 8.91 |
| 2023-12-31 | 2.53 |
| 2023-09-30 | 4.69 |
| 2023-06-30 | 7.61 |
| 2023-03-31 | 10.62 |
| 2022-12-31 | 11.10 |
| 2022-09-30 | 6.70 |
| 2022-06-30 | 7.62 |
| 2022-03-31 | 16.44 |
| 2021-12-31 | 4.67 |
| 2021-09-30 | 31.48 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2019-12-31 | 0.00 |
